DLNX D is a combination therapy designed for effective management of acid reflux and related gastric disorders. It helps reduce excess stomach acid while improving gastric motility. The formulation provides fast relief from heartburn, regurgitation, and epigastric discomfort. DLNX D supports healing of the gastric lining and prevents acid backflow. It is well tolerated and suitable for long-term GERD management.
Clinical advantages designed for effective acid control and digestive support
Provides dual delayed-release acid suppression for 24-hour control.
Effective day & night relief from heartburn and acid reflux.
Promotes faster healing of erosive esophagitis.
Flexible dosing with consistent efficacy regardless of meal timing.
Enhances gastric motility and accelerates gastric emptying.
Relieves nausea, vomiting, and post-meal fullness.
Improves esophageal clearance, reducing reflux episodes.
Non-sedating prokinetic with good tolerability.
Dexlansoprazole Provides dual delayed-release acid suppression for 24-hour control. Effective day & night relief from heartburn and acid reflux. Promotes faster healing of erosive esophagitis. Flexible dosing with consistent efficacy regardless of meal timing.
Domperidone Enhances gastric motility and accelerates gastric emptying. Relieves nausea, vomiting, and post-meal fullness. Improves esophageal clearance, reducing reflux episodes. Non-sedating prokinetic with good tolerability.
DLNX D is indicated for management of acid-related and gastrointestinal disorders.